Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
4.550
-0.140 (-2.99%)
At close: Jul 20, 2026, 4:00 PM EDT
4.550
0.00 (0.00%)
Pre-market: Jul 21, 2026, 4:16 AM EDT
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $357.27 million as of July 20, 2026. Its market cap has increased by 59.43% in one year.
Market Cap
357.27M
Enterprise Value
171.60M
1-Year Change
59.43%
Ranking
Category
Stock Price
$4.55
ChartMarket Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $357.27M, an increase of 31.66%. That is a compound annual growth rate of 10.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 357.27M | -50.70% |
| Dec 31, 2025 | 724.76M | 232.99% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
| Nov 3, 2023 | 271.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sutro Biopharma | 390.57M |
| Atea Pharmaceuticals | 389.73M |
| Larimar Therapeutics | 386.22M |
| Autolus Therapeutics | 383.25M |
| Upstream Bio | 381.48M |
| Rocket Pharmaceuticals | 375.63M |
| Compass Therapeutics | 369.18M |
| Fennec Pharmaceuticals | 364.74M |